Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MS

Mark Sanner — 14 Patents

Pfizer: 14 patents #299 of 5,153Top 6%
Old Saybrook, CT: #15 of 132 inventorsTop 15%
Connecticut: #3,210 of 34,797 inventorsTop 10%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Mark Sanner has been granted 14 US patents while listed as an inventor at Pfizer. The first was granted in 1998 and the most recent in May 2007. Mark Sanner ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Mark Sanner in Old Saybrook, CT, US.

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors Kishor A. Desai, Anton Fliri 2007-05-22 $210,338,000
7101885 Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams John A. Lowe, III 2006-09-05 $341,922,000
7078529 Imidazole derivatives Chris Helal, Christoper B. Cooper, Frank S. Menniti, Patricia Seymour, Michael Ahlijanian +2 more 2006-07-18 $914,508,000
6756385 Imidazole derivatives Chris Helal, Christoper B. Cooper, Frank S. Menniti, Michael Ahlijanian, Annabella Villalobos +2 more 2004-06-29 $204,847,000
6720427 Thiazole derivatives Chris Helal, Christopher B. Cooper 2004-04-13 $281,596,000
6562964 Heterocyclic compounds as inhibitors of rotamase enzymes Mark Ian Kemp, Michael John Palmer, Martin James Wythes 2003-05-13 $363,321,000
6548502 Dopamine D4 ligands for the treatment of novelty-seeking disorders Stevin Zorn, Antor Fliri, Patricia Seymour 2003-04-15 $153,685,000
6372736 Heterocyclic compounds as inhibitors of rotamase enzymes Mark Ian Kemp, Michael John Palmer, Martin James Wythes 2002-04-16 $246,300,000
6284757 Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands 2001-09-04 $482,973,000
6231833 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors Kishor A. Desai, Anton Fliri 2001-05-15 $572,634,000
5889010 Benzimidazole derivatives having dopaminergic activity William Stephen Faraci, Anton Fliri, Brian Thomas O'Neill, Stevin Zorn 1999-03-30 $332,124,000
5883094 Benzimidazolone derivatives with central dopaminergic activity Anton Fliri, Brian Thomas O'Neill, William Stephen Faraci, Stevin Zorn 1999-03-16 $342,327,000
5852031 2,7-substituted octahydro-1H-pyrido1,2-a!pyrazine derivatives Kishor A. Desai, Anton Fliri 1998-12-22 $228,111,000
5714487 2,7-substituted octahydro-pyrrolo1,2-a!pyrazine derivatives 1998-02-03 $296,487,000